NCT06631378

Brief Summary

The purpose of the study is to examine whether incision type has an influence on the development of groin wound complications after operation in the groin in vascular surgery. The main questions it aims to answer are: Does a transverse incision in the groin lead to fewer surgical site complications than a longitudinal incision? Does a transverse incision lead to fewer readmissions, fewer reoperations, shorter length of hospital stay, and a lower amputation rate. Participants will undergo vascular surgery in the groin with either a transverse or longitudinal incision. The incision type will be selected randomly.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
232

participants targeted

Target at P75+ for not_applicable

Timeline
14mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Mar 2025Jul 2027

First Submitted

Initial submission to the registry

September 27, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

June 27, 2025

Status Verified

March 1, 2025

Enrollment Period

2.3 years

First QC Date

September 27, 2024

Last Update Submit

June 24, 2025

Conditions

Keywords

groin wound complicationssurgical site complicationssurgical site complicationvascular surgeryincision typeincision

Outcome Measures

Primary Outcomes (1)

  • Incidence of surgical site complications

    The surgical site complications are defined as follows: * Surgical site infection according to the Szilagy classification: * Dehiscence with separation of the wound edges and exposure of the underlying tissue. * Lymhocele defined as the presence of localized swelling in the groin and verified on ultrasound as an anechoic fluid collection. * Hematoma defined as the presence of localized swelling in the groin with discoloration and verified on ultrasound as an echoic fluid collection.

    35 days after the operation

Secondary Outcomes (5)

  • Reoperation

    35 days after the operation

  • Readmission

    35 days

  • • Length of stay

    35 days

  • Mortality

    35 days

  • Healing of the groin

    35 days

Study Arms (2)

Transverse groin incision

EXPERIMENTAL
Procedure: Transverse groin incision

Longitudinal groin incision

ACTIVE COMPARATOR
Procedure: Longitudinal incision

Interventions

The transverse incision is made parallel to the inguinal ligament either superiorly or inferiorly to the skin crease directly over the femoral artery. The subcutaneous tissue is dissected in the transverse direction till Scarpaes fascia after which the dissection is performed in the longitudinal direction along the line of the vessels. The lymphatic vessels are spared as much as possible. Any damaged lymph vessels are closed with surgical clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage. In case of difficulty with proper access to the femoral arteries, the incision can be extended either medially, laterally, or vertically.

Transverse groin incision

The longitudinal incision is made directly over the femoral artery from the inguinal ligament. The subcutaneous tissue is dissected along the line of the vessel sparing the lymphatic vessels as much as possible. Any damaged lymph vessels are closed with clips. Damages lymph nodes are either removed or the capsule is sutured to prevent lymph leakage.

Longitudinal groin incision

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing vascular reconstruction with a groin incision

You may not qualify if:

  • Patients previously operated with a groin incision.
  • Patients undergoing operation due to trauma, bleeding, or pseudoaneurysm.
  • Patients operated within the first 24 hours of admission.
  • If it prior to the operation is deemed necessary with a muscleplasty.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Vascular Surgery - Lillebaelt Hospital

Kolding, 6000, Denmark

RECRUITING

MeSH Terms

Conditions

Peripheral Arterial DiseaseSurgical Wound

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesWounds and Injuries

Study Officials

  • Kim Trine Maria Mejnert Jørgensen, MD, PhD

    Department of vascular surgery, Kolding Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The trial is a single center superiority randomized clinical trial with two parallel groups with 1:1 randomization to either transverse or longitudinal incision in the groin in vascular surgery with arterial reconstruction.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD-student

Study Record Dates

First Submitted

September 27, 2024

First Posted

October 8, 2024

Study Start

March 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

June 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations